Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
  • Resources
    • Industry Snapshot
    • MassBioHub – Conference Center
    • COVID-19 Resource Center
    • Innovation Services
    • Policy & Advocacy
    • Economic Development
    • Career Center
  • Events
    • Events Calendar
    • Overview of Events
    • Get Involved
  • Membership
    • Member Directory
    • Benefits of Membership
    • Pricing
    • Virtual Member Benefits
    • Member News
    • Become a Member
    • Pay Company Dues
  • MassBio Edge
    • MassBio Edge
    • Preferred Partners
    • Employee Rewards
    • Edge Benefits
  • Initiatives
    • State of Possible 2025 Report
    • Equity, Diversity, and Inclusion
    • Open Letter 2.0 – CEO Pledge for ED&I
    • Value of Health
    • Digital Health
    • BioReady Communities
  • About Us
    • About Us
    • Sponsorship Opportunities
    • Staff
    • Board of Directors
    • MassBioEd
    • FAQs
    • Contact Us
  • News
    • News & Thought Leadership
    • State of Possible Podcast
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
Open search form

Member Directory

Click to Open Main Menu

Cambrex

Life Sciences | Contract Research & Manufacturing
Agawam, MA 866-459-4600 Website cambrex LinkedIn

Overview

Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market.

With over 35 years’ experience and a growing team of over 2,100 experts servicing global clients from sites in North America and Europe, Cambrex is tried and trusted partner in branded and generic markets for API and dosage form development and manufacturing.

Cambrex offers a range of specialist drug substance technologies and capabilities including biocatalysis, continuous flow, controlled substances, solid state science, material characterization and highly potent APIs. In addition, Cambrex can support conventional dosage forms including oral solids, semi-solids and liquids and has the expertise to manufacture specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.

Company News

News

Cambrex Recognized in 2021 CMO Leadership Awards

Feb 19, 2021

Posted by Cambrex

News

Cambrex Completes Major Expansion of Solid Form Screening Facility in Edinburgh

Nov 18, 2020

Posted by Cambrex

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2021 All Rights Reserved